| Net income | |
| Depreciation and amortization | 26.01M |
| Amortization of debt discount | |
| Non-cash equity-based compensation | 12.13M |
| Non-cash asset impairment | 69.66M |
| Non-cash inventory write-off | |
| Non-cash restructuring | |
| Loss on extinguishment of debt | |
| Deferred income taxes | |
| Excess tax benefits from stock option exercises | |
| Other, net | |
| Accounts receivable | -1.18M |
| Inventories | -10.91M |
| Prepaid expenses and other current assets | 3.66M |
| Accounts payable | |
| Accrued expenses, deferred profit and other current liabilities | |
| Income taxes payable | 80K |
| Other, net | 2.19M |
| Net cash provided by operating activities | |
| Capital expenditures | -10.72M |
| Payments for net assets of businesses acquired | |
| Transfers from restricted cash | |
| Proceeds from the maturity of CDARS | |
| Proceeds from sales of short-term investments | |
| Payments for purchases of short-term investments | -78.38M |
| Other | -230K |
| Net cash (used in) provided by investing activities | |
| Proceeds from stock option exercises | 473K |
| Restricted stock tax withholdings | |
| Excess tax benefits from stock option exercises | |
| Purchases of treasury stock | -13.35M |
| Repayments of long-term debt | -252K |
| Other | |
| Net cash (used in) provided by financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | 20K |
| Net (decrease) increase in cash and cash equivalents | 4.79M |
| Cash and cash equivalents at beginning of year | 269.23M |
| Cash and cash equivalents at end of year | 274.02M |
| Transfers from property, plant and equipment to inventory | |
| Transfers from inventory to property, plant and equipment | |
| Sale of property, plant and equipment with note receivable | |